文献速递肿瘤 PET/CT放射性药物与辐射防护

早期68Ga-FAPI-46 PET/CT体积参数在系统性硬化症相关间质性肺病中的探索性评估

Exploratory evaluation of early 68Ga-FAPI-46 PET/CT volume-based parameters in systemic sclerosis-associated interstitial lung disease.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2026-02-02

本研究探索性比较早期(10分钟)与晚期(60分钟)68Ga-FAPI-46 PET参数在系统性硬化症相关间质性肺病(SSc-ILD)中的价值。进展组(n=8)早期总病灶FAPI摄取和受累肺体积显著高于非进展组(n=14),且早期体积参数与肺功能及HRCT参数相关性更强。早期TL-FAPI10min阈值928诊断性能最佳(AUC 0.80)。

要点

  • 早期(10分钟)68Ga-FAPI-46 PET体积参数在进展性SSc-ILD中显著升高。
  • 早期体积参数较晚期及强度参数与肺功能和HRCT相关性更一致。
  • TL-FAPI10min阈值928的AUC为0.80,需前瞻性验证。

核心结论

  • 早期68Ga-FAPI-46 PET/CT体积参数与SSc-ILD近期疾病进展相关。

研究设计与样本

  • 探索性研究比较进展性(n=8)与非进展性SSc-ILD(n=14)的早期(10分钟)和晚期(60分钟)68Ga-FAPI-46 PET参数,进展定义依据INBUILD试验标准。

主要发现

  • 进展组早期总病灶FAPI摄取中位数TL-FAPI10min为1245,非进展组为714(p=0.020)。
  • 进展组早期受累肺体积中位数AV10min为514 ml,非进展组为368 ml(p=0.042)。
  • 早期PET参数较晚期参数与肺功能及定量HRCT参数相关性更强且更一致。
  • 体积参数较强度参数与肺功能及定量HRCT参数相关性更一致。

关键数值与推荐

  • TL-FAPI10min阈值928诊断性能最佳,AUC为0.80。

临床怎么用

  • 早期68Ga-FAPI-46 PET/CT体积参数或有助于识别SSc-ILD近期进展患者,但需前瞻性治疗反应研究验证。

局限性

  • 探索性研究样本量小,阈值需前瞻性验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Systemic sclerosis-associated interstitial lung disease (SSc-ILD) is a severe complication of SSc, characterised by progressive fibrosis and inflammation. Current diagnostic tools do not accurately differentiate progressors from non-progressors, limiting timely intervention. 68Ga-FAPI-46 is a positron emission tomography (PET) tracer targeting fibroblast activation protein alpha (FAP), a marker of activated fibroblasts, with high affinity and retention. Optimal imaging timepoints and PET parameters for 68Ga-FAPI-46 PET/CT imaging in fibroinflammatory disorders remain undefined. This exploratory study investigated early versus late 68Ga-FAPI-46 PET parameters in evaluating SSc-ILD. METHODS: Early (10 min) and late (60 min) 68Ga-FAPI-46 PET parameters were compared between progressive (n = 8) and non-progressive SSc-ILD (n = 14), defined by INBUILD trial criteria. PET parameters were correlated with pulmonary function test (PFT) and HRCT parameters. Optimal thresholds for identified PET parameters were determined by closest-to-(0,1) criterion. RESULTS: Early total lesion FAPI uptake (median TL-FAPI10min 1245 vs. 714, p = 0.020) and affected lung volume (median AV10min 514 ml vs. 368 ml, p = 0.042) were significantly higher in progressors than non-progressors. Early PET parameters showed stronger, more consistent correlations with PFT and quantitative HRCT parameters than late PET parameters. Volume-based compared to intensity-based PET parameters more consistently correlated with PFT and quantitative HRCT parameters. TL-FAPI10min threshold of 928 had the best diagnostic performance (AUC 0.80). CONCLUSION: This exploratory study showed that 68Ga-FAPI-46 PET/CT imaging, specifically early volume-based PET parameters, was associated with patients with recent disease progression of SSc-ILD. Prospective validation in treatment-response studies is needed to confirm the clinical utility of these PET parameters and their identified preliminary thresholds.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Tai SB, Chua WM, Ng CWQ, et al. Exploratory evaluation of early 68Ga-FAPI-46 PET/CT volume-based parameters in systemic sclerosis-associated interstitial lung disease. Eur J Nucl Med Mol Imaging. 2026. PMID: 41627399. doi:10.1007/s00259-025-07710-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。